beta-D-Glucopyranose, 2-deoxy-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-, 1,3,4,6-tetraacetate (CAS No: 10022-13-6) is a key pharmaceutical intermediate used in the synthesis of APIs Gentamicin. This compound serves as an essential raw material in API development and synthesis. Explore detailed chemical properties, molecular data, structure information, and verified global suppliers, manufacturers, and distributors of this API intermediate on apicule.
Alternate Names: 1,3,4,6-Tetra-O-acetyl-2-deoxy-2-phthalimido-beta-D-glucopyranose, 2-Deoxy-2-N-phthalimido-1,3,4,6-tetra-O-acetyl-beta-D-glucopyranose
CAS No: 10022-13-6
PubChem CID: 2728904
Mol Formula: C22H23NO11
Mol Weight: 477.4 g/mol
Used in API: Gentamicin
IUPAC Name: [(2R,3S,4R,5R,6S)-3,4,6-triacetyloxy-5-(1,3-dioxoisoindol-2-yl)oxan-2-yl]methyl acetate
API Intermediate Description: β-D-Glucopyranose, 2-deoxy-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-, 1,3,4,6-tetraacetate is a glucose derivative in which the C-2 hydroxyl is replaced by a phthalimido group, and the hydroxyls at positions 1, 3, 4, and 6 are acetylated. It is commonly used as an intermediate in the synthesis of amino sugars and glycosylated compounds. The acetyl and phthalimido groups protect reactive sites and facilitate selective chemical transformations.
